Atlas Trials

An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with Lenvatinib

Clinical trial NCT06884982 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06884982
Sponsor
Northern Jiangsu People's Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HCC - Hepatocellular Carcinoma
Start date
2025-03-13
Primary completion
2027-09-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.